Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
[WEBINAR] Molecular bioanalysis considerations along the drug development journey 12 days 1 hours 32 mins 30 secs REGISTER NOW!

Video: APA 2015 – Reaching new heights in targeted quantitation with HRMS

15 Mar 2016
Written by Mark Wrona (Waters Corporation)
Chromatography MS (LC–MS/MS, HRMS, IMS)

https://www.youtube.com/watch?v=62i-2wAEAWgMark Wrona, Senior Science Manager at Waters Corporation, discusses the use of high resolution mass spectrometry (HRMS) for targeted quantitation studies. This presentation was originally given at APA 2015 in Boston (MA, USA).

Top content

  • Waters launches the Xevo TQ Absolute XR at ASMS 2025
  • Why NGS ELN deployments fail
  • How can diagnostic laboratories accelerate the clinical adoption of allogeneic cell therapies?

Related tags

HRMS microfluidics
Previous article Next article

Related articles

19 MAR 2012 DATA PROCESSING AND INTERPRETATION

High-resolution MS in drug discovery and development: current applications and future perspectives

5 SEP 2012 DATA PROCESSING AND INTERPRETATION

Measurement and validation of cell-based assays with microfluidics at the National Institute of Standards and Technology

3 NOV 2015 MS (LC–MS/MS, HRMS, IMS)

Press release: SCIEX launches brand new High Resolution Mass Spec system designed exclusively for routine testing use

3 MAY 2011 CHROMATOGRAPHY

Optimization of Exactive Orbitrap™ acquisition parameters for quantitative bioanalysis

31 JAN 2011 CHROMATOGRAPHY

Can MS fully exploit the benefits of fast chromatography?

2 MAR 2018 EXPERT OPINION

Ask the Experts: Bertrand Rochat

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone